期刊文献+

APC/Asef多肽抑制剂结构的优化及生物学活性研究 被引量:1

Structure optimum and biological activity studies of APC/Asef peptide inhibitors
下载PDF
导出
摘要 目的·设计并合成结肠腺瘤息肉易感基因(adenomatous polyposis coli,APC)/鸟苷酸交换因子(APC-stimulated guanine nucleotide exchange factor,Asef)多肽抑制剂,探讨该抑制剂不同构效之间的关系。方法·基于APC-MAI-150复合物结构,一方面在MAI-150多肽N端用3-苯基丙酰(3-phenylpropane)、Glu-Glu(GG)和β-Ala-Ala(β-AA)取代连氨基基团苄氧羰基(carbobenzoxy,CBZ),另一方面尝试将MAI-150中N端第6位Tyr侧链苯环上的对位羟基替换为-CN、-NO_2、-NH_2和-F,设计合成新的7条多肽。荧光偏振活性检测多肽亲和力,并根据活性结果将多肽MDL-3、MDL-4和MDL-5对接到APC蛋白中,联合计算机对接的多肽和APC蛋白的结合模式,探讨该3条多肽的构效关系。结果·新合成的7条多肽中,多肽MDL-5的N端3-phenylpropane连氨基亲和力最高,其半数有效抑制浓度(half maximal inhibitory concentration,IC50)为2.35μmol/L;与MDL-5相比,多肽N端用GG(MDL-6)和β-AA(MDL-7)连接氨基亲和力明显降低;MDL-3和MDL-4的N端第6位Tyr侧链苯环上的对位羟基替换为-NH_2和-F亲和力相比较于替换为-CN(MDL-1)和-NO_2 (MDL-2)要明显提高;但新合成的多肽亲和力均低于MAI-150。结论·改造多肽N端连氨基基团和第6位Tyr侧链苯环上的对位羟基无助于提高多肽的亲和力。 Objective·To design and synthesize APC/Asef peptide inhibitors,and investigate the relationship between the structures and affinity of peptides.Methods·Based on crystal structure of the APC-MAI-150 complex,on the one hand,3-phenylpropane,Glu-Glu(GG)andβ-Ala-Ala(β-AA)were used to replace carbobenzoxy(CBZ)at the N terminal of MAI-150 to bind-NH2;on the other hand,-CN,-NO2,-NH2,and-F were replaced the parahydroxyl on the sixth tyrosine(Tyr)side chain benzene at the N terminal of MAI-150.And seven peptides were synthesized.Fluorescence polarization was applied to test peptide affinity,and molecular design laboratory-3(MDL-3),MDL-4 and MDL-5 were docked into APC protein based on the results of activity.The structure-activity relationship of the three peptides was studied by combining the binding patterns of computer docked peptide and APC protein.Results·Among the seven peptides,the N terminal 3-phenylpropane linked-NH2 of peptide MDL-5 had the highest affinity,which IC50 was 2.35μmol/L.Compared with MDL-5,the affinity of MDL-6 and MDL-7 were significantly reduced.The para-hydroxyl on the sixth Tyr side chain benzene at the N terminal replaced with-NH2(MDL-3)and-F(MDL-4),which the affinity were higher than-CN(MDL-1)and-NO2(MDL-2).However,the affinity of newly synthesized peptides was lower than MAI-150.Conclusion·Transforming peptide N terminal linked-NH2 and the para-hydroxyl group on the sixth Tyr side chain benzene doesn't help to improve the affinity of peptides.
作者 钱金星 张健 QIAN Jin-xing;ZHANG Jian(Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education,Shanghai Jiao Tong University College of Basic Medical Sciences,Shanghai 200025,China)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2018年第10期1139-1144,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家重点基础研究发展计划项目(973计划)(2015CB910403)~~
关键词 结肠腺瘤息肉易感基因/鸟苷酸交换因子 多肽抑制剂 构效关系 APC/Asef peptide inhibitor structure-activity relationship
  • 相关文献

参考文献1

二级参考文献34

  • 1Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
  • 2Rustgi AK. The genetics of hereditary colon cancer. Genes Dev 2007; 21:2525-2538.
  • 3Hirschl D, Bayer P, Muller O. Secondary structure of an ar- madillo single repeat from the APC protein. FEBS Lett 1996; 383:31-36.
  • 4Graham TA, Weaver C, Mao F, Kimelman D, Xu W. Crystal structure of a beta-catenin/Tcf complex. Cell 2000; 103:885- 896.
  • 5Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI. Mecha- nism of phosphorylation-dependent binding of APC to beta- catenin and its role in beta-catenin degradation. Mol Cell 2004; 15:511-521.
  • 6Huber AH, Weis WI. The structure of the beta-catenin/E- cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 2001 ; 105:391-402.
  • 7Sampietro J, Dahlberg CL, Cho US, Hinds TR, Kimelman D, Xu W. Crystal structure of a beta-catenirdBcl9/Tcf4 complex. Mol Cell 2006; 24:293-300.
  • 8Xing Y, Clements WK, Kimelman D, Xu W. Crystal structure of a beta-catenirdaxin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev 2003; 17:2753- 2764.
  • 9Xing Y, Clements WK, Le Trong I, et al. Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell 2004; 15:523-533.
  • 10Xu W, Kimelman D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci 2007; 120:3337-3344.

共引文献5

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部